2022 | July / August 2022

Forging a new frontier in flow chemistry & continuous manufacturing

by cyb2025

STEPHEN HOULDSWORTH
VP, Global Head of Platform Management & Marketing, CordenPharma International

ABSTRACT

The pharmaceutical industry is rightfully lauded for its innovation. In fact, we choose to use the word “innovator” to describe the companies that develop new therapies..

The pharmaceutical industry is rightfully lauded for its innovation. In fact, we choose to use the word “innovator” to describe the companies that develop new therapies to solve our unmet medical needs in the future. Why then, does the industry continue to be a slow adopter of more efficient technologies that have demonstrated similar capabilities in the petrochemical and bulk chemical industries for decades?

ABOUT THE AUTHOR

Dr. Stephen Houldsworth is currently the VP, Global Head of Platform Management & Marketing. With over twenty years in the CDMO industry, Stephen joined CordenPharma in 2017 as Director, Global Small Molecules & Antibiotics Platforms. Prior to joining CordenPharma Stephen held various senior positions in R&D, Manufacturing, Operations, Business Development and Sales in Dalton Pharma Services and most recently Apotex Pharmachem. Stephen has a Ph.D. in organic chemistry from the University of Nottingham (UK) where he conducted research in the group of Prof. G. Pattenden, followed by a postdoctoral stay in the group of V. Snieckus at the University of Waterloo (CA).

Login